# Abbott Laboratories (ABT) — Q4-2023 Earnings Results

**Report date:** 2024-01-24 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q4-2023

## Post-Earnings Brief

### Headline

Abbott Labs Meets EPS Expectations, Stock Down 2.83%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.19 | N/A | +0.00% |

### Management Commentary

**Tone:** Neutral

Overall, management expressed a steady outlook but acknowledged some market pressures. There was no significant change in their strategic direction.

**Key quotes:**

> Management highlighted stability in core product lines.

> They noted ongoing challenges in certain market segments.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Abbott Labs reported earnings that met expectations for EPS, but the stock fell by 2.83% following the announcement. The decline may reflect investor concerns about market challenges and the lack of new guidance. Overall, the company seems to be maintaining stability, but uncertainty remains in certain areas.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q4-2023_